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hWorld Health Organization, Geneva, SwitzerlandThe authors wish to correct two typographical errors in the manu-
script. In the Methods (Section 5.3: Assay optimization), the concen-
tration unit of dNTPs was wrongly written as 800 nM (nanomolar)
and should be corrected to 800mM (millimolar). Furthermore, in
Table S1 of the Supplementary material, the primers and probe
sequences for Pfhrp3 are incorrect. They should be written:
Pfhrp3_F2: 5’-ACGGATTTCATTTTAACCCTTCACGA-‘3, Pfhrp3_R2:Table S1
Primers used for the three parasite target genes an
Pfhrp2_R2 primer was modified at 3’ end (T->G, h





















DOI of original article: https://doi.org/10.1016/j.ebiom.2020.102757.
* Corresponding author.
E-mail address: Khalid.Beshir@lshtm.ac.uk (K.B. Beshir).
https://doi.org/10.1016/j.ebiom.2021.103261
2352-3964/© 2021 The Author(s). Published by Elsevier B.V. This is an open access article un5’-TGAGAATCATCAAAACAAGCATTAGC-‘3 and Pfhrp3_probe: JOE’-
ACAATTCCCATACTTTACATCATGCA-‘3 BHQ1. A revised Table S1 is
included (below). The primers and probe sequences of Pfhrp3 in
Figure 3S of the supplementary material are correct. The authors
regret any confusion caused and appreciate the opportunity to cor-
rect these mistakes
The authors would like to apologise for any inconvenience caused.d one human gene.
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